Hangeoreum: A Self-Paced Web-Based Program for Loneliness and Connectedness Among Korean Immigrants Aged 50 and Older
NCT07917013, Not applicable, Recruiting, University of South Florida
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Hangeoreum: A Self-Paced Web-Based Program for Loneliness and Connectedness Among Korean Immigrants Aged 50 and Older | ClinicalTrials.gov |
| NCT number | NCT07917013 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 40 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | University of South Florida | ClinicalTrials.gov |
| Conditions | Loneliness, Korean, Older Adults (50-94 Years), Immigrant | ClinicalTrials.gov |
| Interventions | Hangeoreum | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-10 | ClinicalTrials.gov |
Registered outcomes 18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Enrollment rate | From the start of recruitment through completion of enrollment, up to 6 months. | The enrollment rate will be calculated as the number of participants who provide informed consent and complete the baseline assessment divided by the number of eligible individuals invited to participate in the study. | ClinicalTrials.gov |
| Primary | Retention | Baseline through post-intervention (approximately 6-7 weeks) | Retention will be defined as the proportion of enrolled participants who complete the post-intervention assessment. | ClinicalTrials.gov |
| Primary | Web-based module completion | Baseline through post-intervention (approximately 6-7 weeks) | Web-based module completion will be defined as the number of Hangeoreum modules completed by each participant (range 0-6 modules). Module completion will be determined based on completion of the module completion survey at the end of each module, as recorded in Canvas. | ClinicalTrials.gov |
| Secondary | Acceptability of the Hangeoreum Program | Post-intervention (approximately 6-7 weeks) | Acceptability will be assessed using the Acceptability of Intervention Measure (AIM). AIM includes four items rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Mean scale scores range from 1 to 5, with higher scores indicating greater perceived acceptability. | ClinicalTrials.gov |
| Secondary | Appropriateness of the Hangeoreum program | Post-intervention (approximately 6-7 weeks) | Appropriateness will be assessed using the Intervention Appropriateness Measure (IAM). IAM includes four items rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Mean scale scores range from 1 to 5, with higher scores indicating greater perceived appropriateness. | ClinicalTrials.gov |
| Secondary | Perceived feasibility of the Hangeoreum program | Post-intervention (approximately 6-7 weeks) | Perceived feasibility will be assessed using the Feasibility of Intervention Measure (FIM). FIM includes four items rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Mean scale scores range from 1 to 5, with higher scores indicating greater perceived feasibility. | ClinicalTrials.gov |
| Secondary | Usability of the Hangeoreum program | Post-intervention (approximately 6-7 weeks) | Usability will be assessed using the System Usability Scale (SUS). SUS includes 10 items rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Responses will be scored using standard SUS procedures to generate a total score ranging from 0 to 100, with higher scores indicating better perceived usability. | ClinicalTrials.gov |
| Secondary | Change in UCLA Loneliness Scale Version 3 (UCLA-LS) scores from baseline to post-intervention | Baseline to post-intervention (approximately 6-7 weeks) | The UCLA Loneliness Scale Version 3 (UCLA-LS) is a 20-item self-report questionnaire assessing subjective feelings of loneliness and social isolation. Items are rated on a 4-point scale (1 = never to 4 = often). After appropriate reverse scoring, total scores range from 20 to 80, with higher scores indicating greater loneliness. | ClinicalTrials.gov |
| Secondary | Change in Social Connectedness Scale-Revised (SCS-R) scores from baseline to post-intervention | Baseline to post-intervention (approximately 6-7 weeks) | The Social Connectedness Scale-Revised (SCS-R) is a 20-item self-report questionnaire assessing individuals' sense of interpersonal closeness and connectedness with others. Items are rated on a 6-point scale (1 = strongly disagree to 6 = strongly agree). After appropriate reverse scoring, total scores range from 20 to 120, with higher scores indicating greater social connectedness. | ClinicalTrials.gov |
| Secondary | Change in Patient Health Questionnaire-9 (PHQ-9) scores from baseline to post-intervention | Baseline to post-intervention (approximately 6-7 weeks) | The PHQ-9 is a nine-item self-report questionnaire assessing depressive symptoms over the past two weeks. Items are rated from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 27, with higher scores indicating greater severity of depressive symptoms. | ClinicalTrials.gov |
| Secondary | Change in Generalized Anxiety Disorder-7 (GAD-7) scores from baseline to post-intervention | Baseline to post-intervention (approximately 6-7 weeks) | The GAD-7 is a seven-item self-report questionnaire assessing anxiety symptoms over the past two weeks. Items are rated from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 21, with higher scores indicating greater anxiety symptoms. | ClinicalTrials.gov |
| Secondary | Change in Perceived Stress Scale-10 (PSS-10) scores from baseline to post-intervention | Baseline to post-intervention (approximately 6-7 weeks) | The PSS-10 is a 10-item self-report questionnaire assessing perceived stress over the past month. Items are rated from 0 (never) to 4 (very often). After appropriate reverse scoring, total scores range from 0 to 40, with higher scores indicating greater perceived stress. | ClinicalTrials.gov |
| Secondary | Change in Brief Experiential Avoidance Questionnaire (BEAQ) scores from baseline to post-intervention | Baseline to post-intervention (approximately 6-7 weeks) | The BEAQ is a 15-item self-report questionnaire assessing experiential avoidance, or the tendency to avoid unwanted thoughts, feelings, and experiences. Items are rated on a 6-point scale (1 = strongly disagree to 6 = strongly agree). Total scores range from 15 to 90, with higher scores indicating greater experiential avoidance. | ClinicalTrials.gov |
| Secondary | Change in Cognitive Fusion Questionnaire-7 (CFQ-7) scores from baseline to post-intervention | Baseline to post-intervention (approximately 6-7 weeks) | The CFQ-7 is a seven-item self-report questionnaire measuring cognitive fusion, or the extent to which individuals become entangled with their thoughts. Items are rated from 1 (never true) to 7 (always true). Total scores range from 7 to 49, with higher scores indicating greater cognitive fusion. | ClinicalTrials.gov |
| Secondary | Change in Engaged Living Scale-9 (ELS-9) scores from baseline to post-intervention | Baseline to post-intervention (approximately 6-7 weeks) | The ELS-9 is a nine-item self-report questionnaire assessing values-based living, including clarity of personal values and engagement in meaningful activities. Items are rated on a 5-point scale (1 = completely disagree to 5 = completely agree). Total scores range from 9 to 45, with higher scores indicating greater values-based engagement. | ClinicalTrials.gov |
| Secondary | Change in Multidimensional Psychological Flexibility Inventory-24 (MPFI-24) scores from baseline to post-intervention | Baseline to post-intervention (approximately 6-7 weeks) | The MPFI-24 is a 24-item self-report questionnaire assessing multidimensional psychological flexibility and inflexibility processes. Items are rated on a 6-point scale (1 = never true to 6 = always true). Psychological flexibility and psychological inflexibility are represented by separate composite scores, with higher scores indicating greater levels of the respective construct. | ClinicalTrials.gov |
| Other | User Experiences (Semi-structured Individual Interviews) | Post-intervention (approximately 6-7 weeks) | Individual semi-structured interviews (approximately 40 minutes) will be conducted in Korean via videoconference after program completion. Interviews will explore participants' experiences with Hangeoreum, perceived changes in loneliness and connectedness, cultural relevance, program usability and accessibility, perceived benefits, and suggestions for program improvement. Interview data will be analyzed using thematic analysis. | ClinicalTrials.gov |
| Other | Participant Perceptions of the Hangeoreum Weekly Modules | Post-intervention (approximately 6-7 weeks) | Twelve additional program feedback items will assess participants' perceptions of the weekly modules, including clarity, ease of use, cultural relevance, visual design, engagement, perceived usefulness, manageability, and overall satisfaction. Items are rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Item-level ratings will be summarized descriptively, with higher scores indicating more favorable perceptions. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)